{"id":"https://genegraph.clinicalgenome.org/r/5331624b-5878-45b6-a967-b3e46bf8a70av1.0","type":"EvidenceStrengthAssertion","dc:description":"The CCDC40 gene was first reported in relation to primary ciliary dyskinesia in 2011 (Becker-Heck et al., PMID: 21131974). The specific disease entity, primary ciliary dyskinesia 15, is one of at least 40 different primary ciliary dyskinesias distinguished by a single monogenic cause. Affected patients frequently present as neonates with respiratory distress, recurrent chest infections, cough and/or pneumonia (PMID: 23255504). Recurrent upper and lower respiratory infections are highly prevalent and include sinusitis, rhinorrhea, chronic cough, pneumonia, and bronchitis. Patients frequently exhibit chronic cough, age-dependent bronchiectasis, and/or otitis media. Heterotaxy is present with approximately 50% penetrance, most often in the form of situs inversus totalis. Immotile sperm and female infertility are also reported for some affected patients. Biopsies of the airway epithelium show a variable motility defect including static cilia and rigid cilia with variable fast, flicking movements but reduced beating amplitudes. Defects in axonemal morphology include shifting or absence of central pairs, disorganization of peripheral microtubular doublets, abnormalities in both radial spokes and nexin links, and usually complete but sometimes partial absence of inner dynein arms. Outer dynein arms appear to be normal/intact. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, the molecular mechanism (biallelic loss of function) and mode of inheritance (autosomal recessive) was found to be consistent among unrelated patients, while the phenotypic variability among them appeared to represent a spectrum of disease rather than separate disease entities. Therefore, cases caused by inherited CCDC40 variants have been lumped into a single disease entity, referred to as primary ciliary dyskinesia 15 (MONDO:0013435, OMIM #613808). Seventeen suspected pathogenic variants were scored as part of this curation (eight nonsense, seven frameshift, and two predicted to trigger frameshift by affecting splicing), which have been collectively reported in thirty-six probands in two publications (PMID: 21131974, PMID: 23255504). More case-level evidence is available in the literature (PMID: 22499950, PMID: 25619595, PMID: 32502479), but its inclusion in this curation was not necessary to reach the maximum score for genetic evidence (12 points). This gene-disease relationship has not been studied in case-control studies at the single variant level or aggregate variant level. The mechanism of pathogenicity appears to be biallelic loss of function, characterized in some cases by variants likely to trigger the absence of a gene product (PMID: 21131974, PMID: 23255504). All probands scored in this curation harbored two variant alleles within the CCDC40 locus. This gene-disease association is also supported by experimental evidence that CCDC40 localizes specifically to tissue types relevant to disease and known to have motile cilia, including the ovary (PMID: 10997877) and Kupfferâ€™s vesicle in the developing zebrafish embryo (PMID: 21131974). Biochemical and immunoprecipitation studies from Chlamydomonas reinhardtii indicate that the orthologs of CCDC40 and CCDC39 form a complex that functions as an axonemal molecular ruler, defining the length of the cilia, radial spoke periodicity, and both the presence and orientation of components of the inner dynein arms and nexin-dynein regulatory complex (PMID: 25395538). Phenotypes of affected human patients are recapitulated by various model organisms with CCDC40 loss-of-function, including defective structure and motility in Chlamydomonas reinhardtii (PMID: 26348919), left-right patterning defects and defective ciliary ultrastructure in zebrafish (PMID: 21131974), and situs inversus and defective ciliary ultrastructure in mice (PMID: 21131974). Restoring wild-type CCDC40 expression successfully rescues these phenotypes in both Chlamydomonas (PMID: 26348919) and zebrafish (PMID: 21131974) models. Additional evidence is available in the literature (PMID: 10997877, PMID: 28182636) but its inclusion in this curation was not necessary to reach the maximum score for experimental evidence (6 points). In summary, CCDC40 is definitively associated with primary ciliary dyskinesia 15. This has been repeatedly demonstrated in both research and diagnostic settings, and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification. This classification was approved by the ClinGen Motile Ciliopathy GCEP on November 11, 2021 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5331624b-5878-45b6-a967-b3e46bf8a70a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e9c192c6-9f74-4beb-85ba-a42199e9794a","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e9c192c6-9f74-4beb-85ba-a42199e9794a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2021-12-10T03:15:08.185Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e9c192c6-9f74-4beb-85ba-a42199e9794a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2021-12-10T03:15:31.752Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9c192c6-9f74-4beb-85ba-a42199e9794a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9c192c6-9f74-4beb-85ba-a42199e9794a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc49254d-468f-4684-beab-a24b2a5755b6","type":"EvidenceLine","dc:description":"The model recapitulates the left-right asymmetry defects of the human patients, and has ciliary defects detectable at the cellular level. The model was scored conservatively due to its approach in silencing the entire Ccdc40 gene product rather than introducing a truncating or point mutation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c8dd3ff8-7f3d-4e09-8290-dd1aca988983","type":"Finding","dc:description":"Laterality defects are induced by injection of morpholinos targeting Ccdc40 (Figures 2e, 2g, 2i) and can be rescued by co-injection of Ccdc40 mRNA (Figures 2h, 2j). These zebrafish phenotypes not only match human patient phenotypes, but also similar phenotypes identified in a previously characterized zebrafish model (PMID: 18178183, PMID: 17576052) that was genotyped in this study and found to harbor a C>T substitution in the Ccdc40 locus that introduces a p.Gln778Ter nonsense variant (Figures 2d, 2f, 2i, 2j). Scanning electron microscopy showed reduced ciliary length in Kupffer's vesicle and pronephric tubules of the affected animals (Figures 3c, 3d, 3g, 3h).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Ccdc40 silencing triggers laterality defects in zebrafish.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/058c82c1-b965-4c92-94cd-597fb4ef58a6","type":"EvidenceLine","dc:description":"The model is a good match for the variant profile of the human patients in that it recapitulates motile cilia phenotypes at the cellular level and harbors a nonsense mutation (c.334G>A (p.Gln112Ter)) in the Chlamydomonas ortholog of human CCDC40. On the other hand, most of the organism-level phenotypes cannot be tested / recapitulated in a Chlamydomonas model. The origin of the model in a mutagenic screen rather than a targeted disruption of the gene of interest also introduces a small possibility of other linked contributions to the genetic basis of disease.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50d1aab8-dee9-4128-805a-045d35f3c3b2","type":"Finding","dc:description":"Mutations in fap172, the Chlamydomonas ortholog of CCDC40, cause short flagella and defective motility (Figure 1). Abnormalities in axonemal contents include absence of CCDC39, Tektin, DRC2, and DRC3 (Figure 3). This is consistent with other Chlamydomonas studies indicating that CCDC40 collaborates with CCDC39 to serve as docking sites for axonemal structures along the doublet microtubules (PMID: 25395538). These phenotypes partially recapitulate the ciliary dyskinesia and abnormal ciliary morphology observed in the affected human patients harboring pathogenic *CCDC40* variants. Shorter respiratory cilia have been reported in at least one such patient (PMID: 21131974). Patient cilia also exhibit a characteristic mixed beating pattern, with some cilia beating with reduced amplitude (stiffness) and others showing no motility (PMID: 23255504).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26348919","rdfs:label":"CCDC40 mutation causes short flagella and defective motility","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a3e89a99-2119-4b87-9f02-a6a817a15532","type":"EvidenceLine","dc:description":"The strongest candidate for the causal variant in the mouse model is a single base substitution (C>A) encoding the p.Ser792Ter nonsense variant in the mouse Ccdc40 protein product, orthologous to a human p.Ser742Ter variant. One weakness of the model is its mutagenic origin and homozygous state (making it difficult to definitively identify the causal variant). Another weakness is the lack of characterization of respiratory phenotypes. On the other hand, the mouse data are not only a match for the human disease in its body patterning phenotypes, but also in the embryonic studies recapitulating the human ciliary defects at the cellular / microscopic level.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae30ce10-ab68-4183-907b-20e88f77ed18","type":"Finding","dc:description":"The mouse model recapitulates the left-right patterning defects (situs inversus, left isomerism, etc.) that are characteristic of the human patients. At the cellular level, ciliary length is disrupted in a region of the mouse embryo responsible for establishing left-right asymmetry. This closely parallels the disrupted ciliary ultrastructure observed in affected human patients. The variant type (nonsense) also matches the human pathogenic variants both in mechanism (loss-of-function) and mode of inheritance (homozygous / biallelic).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Left-right asymmetry defect in Ccdc40 loss-of-function mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c18b9697-2c03-4b65-8cf5-4dd3c77cab19","type":"EvidenceLine","dc:description":"The model harbors a mutation that matches the human patient mode of inheritance, and triggers similar laterality defects and ciliary dyskinesia. The model is imperfect because of the spontaneous rather than targeted occurrence of the variant. It has been scored conservatively to reflect this and to avoid over-scoring zebrafish models in general.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3614c0e-2d2d-4b57-bbc0-1d89924d7618","type":"Finding","dc:description":"This previously characterized zebrafish model (PMID: 18178183, PMID: 17576052) was genotyped in this study and found to harbor a C>T substitution in the Ccdc40 locus that introduces a p.Gln778Ter nonsense variant (Figure 2d). Phenotypes are characterized in Figures 2f, 2i, and 2j, including rescue by the addition of Ccdc40 mRNA. Scanning electron microscopy shows defects in central pair positioning in cilia from the pronephros and in the number of cilia relative to the control (Figures 3i, 3j, 3k, 3l). A previous study showed abnormal ciliary motility characterized by a quick flickering movement with a limited range of motion relative to the wild-type (Supplementary Video 4 from PMID: 18178183).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Homozygous Ccdc40 loss triggers zebrafish laterality defects","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2cd8c89b-3945-41df-8e71-d4c5b9007925","type":"EvidenceLine","dc:description":"Evidence was down-scored because two distinct morpholinos were injected into zebrafish embryos to completely silence Ccdc40 expression, rather than introducing a variant. It is unclear how the co-injected Ccdc40 mRNA and morpholinos might have interacted (directly rather than through separate effects on Ccdc40 abundance).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1103c24-c6b6-4263-b0b1-53f7e09f81fe","type":"Finding","dc:description":"The morpholino-triggered curly-tail down phenotype (Figure 2g) was rescued by co-injection of Ccdc40 mRNA (Figure 2h). The heart looping defect was partially rescued as well (from 35% penetrance of leftward looping of the heart to 8% penetrance, Figure 2j). Heart morphology was the only indicator of left-right patterning scored, while left-right organ situs was not.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Ccdc40 mRNA co-injection rescues Zebrafish morpholino model.","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4fa69900-d150-4557-b2d4-29cad2c4f981","type":"EvidenceLine","dc:description":"Rescue transformation was performed with wild-type CCDC40 on a bacterial artificial chromosome, while the endogenous nonsense variant was c.334G>A (p.Gln112Ter). The experiment was conservatively scored because the experimental design did not include detail about the expression level of the exogenous CCDC40, or about the extent to which ciliary motility was restored.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0cfaa439-49aa-44cc-b0c0-024c4e0d0b75","type":"Finding","dc:description":"Flagellar shortening was reversed to yield wild-type flagellar length (Figure 1A).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26348919","rdfs:label":"CCDC40 expression restores flagellar length and motility.","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/e9c192c6-9f74-4beb-85ba-a42199e9794a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95d04e17-e068-4c07-9819-560c0fd5696f","type":"EvidenceLine","dc:description":"The molecular function of the CCD39/CCDC40 complex in Chlamydomonas as a molecular ruler that defines the presence and orientation of components within the flagellum explains the known requirement of CCDC40 for normal ciliary length, axoneme structure, and motility. The evidence has only been moderately up-scored because of its origin in Chlamydomonas rather than a model system closer to the human patients.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/202aeaf9-753b-476d-9f83-fce0674e6e04","type":"Finding","dc:description":"The function of the complex containing FAP172 and FAP59 (the Chlamydomonas orthologs of CCDC40 and CCDC39) as a molecular ruler that determines the length of cilia/flagella (Figure 1A) and the presence of ciliary / flagellar components (Figures 1C, 1D) is consistent with the patient phenotype of abnormal ciliary motility. The requirement of the CCDC39 and CCDC40 orthologs for normal radial spoke periodicity (Figures 2B, 2C, 2D) is also consistent with its proposed function as a molecular ruler, as well as the abnormal axonemal organization observed in the respiratory motile cilia of some patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25395538","rdfs:label":"CCDC39/CCDC40 complex is a ciliary molecular ruler","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f237ad43-b79d-45ad-9935-77d6d349d511","type":"EvidenceLine","dc:description":"CCDC40 physically interacts with CCDC39 in the axoneme, and biallelic variants in either gene have been linked to primary ciliary dyskinesia. This data is complemented by the finding that mutation of either gene in Chlamydomonas results in the absence of both proteins from the axoneme.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2644b38-06cd-4030-82fa-f46dd9874845","type":"Finding","dc:description":"Immunoprecipitation of either FAP59 (CCDC39) or FAP172 (CCDC40) from flagellar axonemes successfully co-immunoprecipitates both proteins (Figure 1E), indicating the presence of a CCDC39/CCDC40 complex. This is consistent with the finding that mutation of either component causes absence of both proteins from flagellar axonemes (Figures 1C, 1D).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25395538","rdfs:label":"CCDC40 forms a complex with CCDC39 in flagellar axonemes.","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/680c16a6-57e0-4c84-9a33-36eb8d330bc2","type":"EvidenceLine","dc:description":"This finding links Ccdc40 localization to motile cilia, particularly during stages of embryonic development when left-right patterning is being established.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2af95d6b-deae-4779-a661-b929266441ea","type":"Finding","dc:description":"Ccdc40 mRNA is expressed in regions of the zebrafish embryo known to contain motile cilia, specifically Kupffer's vesicle, the floorplate, pronephric tubules, and otic vesicle (Figures 2a, 2b, 2c). Note:  A previous study complemented this one by finding that CCDC40 mRNA expression in human tissues is highest in human tissues such as the ovary and corpus callosum, which are known to contain motile cilia (Figure 3 in PMID: 10997877).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Ccdc40 expression in ciliated regions of zebrafish embryos","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/420915d0-38fd-445f-9181-f82d3262e849","type":"EvidenceLine","dc:description":"This result complements a similar expression experiment in mouse embryo, previously scored as part of a separate paper (PMID: 21131974). The combined strength of the two experiments was evaluated and scored as part of a single entry into the GCI (PMID: 21131974).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65cff90f-742a-4e2c-ad4f-57652bda60f9","type":"Finding","dc:description":"Expression was profiled using reverse transcription-coupled PCR, with ELISA-based quantification of products. CCDC40 mRNA expression is highest in human tissues such as the ovary and corpus callosum, which are known to contain motile cilia (Figure 3).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10997877","rdfs:label":"Expression of CCDC40 mRNA in human tissues","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/e9c192c6-9f74-4beb-85ba-a42199e9794a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5734c41a-eaa1-4991-be30-840dd27af529_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47cd7086-f4ce-49fd-ba72-8ee976d0481b","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47cd7086-f4ce-49fd-ba72-8ee976d0481b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.248del (p.Ala83fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338795"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/5734c41a-eaa1-4991-be30-840dd27af529","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC337-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012387","obo:HP_0031417","obo:HP_0012735","obo:HP_0002205","obo:HP_0002643","obo:HP_0012258","obo:HP_0000388","obo:HP_0000246","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/47cd7086-f4ce-49fd-ba72-8ee976d0481b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/fc6bdd1a-a473-4406-b327-2fbed57668eb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e96c4273-201a-4fa3-a382-a04b6bc7183c","type":"EvidenceLine","dc:description":"This single base substitution in an essential splice site in intron 16 is predicted to trigger a frameshift that disrupts ~21% of the protein product. While it has been upscored for recurrence in another proband from an apparently unrelated family (also PMID: 21131974), it has been scored at half-strength in this proband.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e96c4273-201a-4fa3-a382-a04b6bc7183c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a1bd339-17bd-46c1-a3a8-cad7da84a6f5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.2712-1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8814325"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc6bdd1a-a473-4406-b327-2fbed57668eb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD8-II:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3a1bd339-17bd-46c1-a3a8-cad7da84a6f5"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Otitis media required repeated grommet insertion. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002110","obo:HP_0012735","obo:HP_0002090","obo:HP_0002205","obo:HP_0002643","obo:HP_0000388","obo:HP_0002783","obo:HP_0012258","obo:HP_0012265","obo:HP_0004469"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e96c4273-201a-4fa3-a382-a04b6bc7183c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/782f82c2-c956-4ae8-a97a-bf0f8b1d3506_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3cb3e492-c9b6-42f5-a65c-6067ff1f2f8f","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3cb3e492-c9b6-42f5-a65c-6067ff1f2f8f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/782f82c2-c956-4ae8-a97a-bf0f8b1d3506","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC281-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012387","obo:HP_0012258","obo:HP_0000388","obo:HP_0002090","obo:HP_0012265","obo:HP_0000246","obo:HP_0031417","obo:HP_0002205","obo:HP_0002643","obo:HP_0012735"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3cb3e492-c9b6-42f5-a65c-6067ff1f2f8f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/f875a175-a9f0-4c93-af08-8c4451c42044_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88b1aab2-bfa1-420a-80ab-315c25d2aff4","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88b1aab2-bfa1-420a-80ab-315c25d2aff4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/42a8c90c-5924-47f3-84f0-e6921bc3cdc3","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.961C>T (p.Arg321Ter) is a nonsense variant in exon 7 that is predicted to trigger either nonsense mediated decay or a truncation disrupting ~72% of the protein product. Since it is a recurrent variant that has already been scored at full strength in another proband from an apparently unrelated family (also from PMID: 23255504), it was scored at half strength for this proband.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42a8c90c-5924-47f3-84f0-e6921bc3cdc3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/97856c42-cc23-4d00-9e0a-61cca70969f6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.961C>T (p.Arg321Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338083"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f875a175-a9f0-4c93-af08-8c4451c42044","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC533-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},{"id":"https://genegraph.clinicalgenome.org/r/97856c42-cc23-4d00-9e0a-61cca70969f6"}],"detectionMethod":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002205","obo:HP_0002643","obo:HP_0000246","obo:HP_0012258","obo:HP_0012735","obo:HP_0031417","obo:HP_0000388","obo:HP_0002090","obo:HP_0012265","obo:HP_0002110","obo:HP_0012387"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/88b1aab2-bfa1-420a-80ab-315c25d2aff4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/42a8c90c-5924-47f3-84f0-e6921bc3cdc3_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d9d2e5b2-d4fd-4738-b40a-ab782bf3b90a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb3d6a43-34f1-4951-974d-023c181d4dab","type":"EvidenceLine","dc:description":"This nonsense variant in exon 14 is predicted to trigger either nonsense mediated decay or a truncation that disrupts ~29% of the protein product. It was up-scored conservatively despite its proximity to the C-terminus and the reported consanguinity of the parents.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb3d6a43-34f1-4951-974d-023c181d4dab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/de1d1563-8ed7-4d0f-891b-dd2edf09c7e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.2440C>T (p.Arg814Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/569156"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d9d2e5b2-d4fd-4738-b40a-ab782bf3b90a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC130-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/de1d1563-8ed7-4d0f-891b-dd2edf09c7e9"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002643","obo:HP_0002205","obo:HP_0002090","obo:HP_0002110","obo:HP_0012387","obo:HP_0000246","obo:HP_0031417","obo:HP_0000388","obo:HP_0012258","obo:HP_0012735","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fb3d6a43-34f1-4951-974d-023c181d4dab_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/71a73708-589b-4b5c-97c1-8cc322814c29_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8900d66c-3c93-4b14-83a7-6fe0254a7154","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8900d66c-3c93-4b14-83a7-6fe0254a7154_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/71a73708-589b-4b5c-97c1-8cc322814c29","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC188-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002643","obo:HP_0012387","obo:HP_0012258","obo:HP_0000246","obo:HP_0031417","obo:HP_0012735","obo:HP_0002090","obo:HP_0002110","obo:HP_0002205","obo:HP_0000388","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8900d66c-3c93-4b14-83a7-6fe0254a7154_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/b612a814-74f8-4826-a326-d9cefd6a8c1d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6d981b6-2802-4b2a-8fdd-299fa2dfe475","type":"EvidenceLine","dc:description":"This single base substitution in an essential splice site in intron 16 is predicted to trigger a frameshift that disrupts ~21% of the protein product. Up-scoring was performed to reflect its recurrence in two other probands from this paper (PMID: 23255504), despite its presence in this proband in a homozygous state.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6d981b6-2802-4b2a-8fdd-299fa2dfe475_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a1bd339-17bd-46c1-a3a8-cad7da84a6f5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/b612a814-74f8-4826-a326-d9cefd6a8c1d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD114-II:1,","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3a1bd339-17bd-46c1-a3a8-cad7da84a6f5"},"detectionMethod":"Whole exome sequencing, likely followed by Sanger sequencing of PCR-amplified exons and adjacent intronic regions from CCDC39 and CCDC40","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Neonatal pneumonia was diagnosed. Immotile sperm was cited as a phenotype despite the female sex of the proband, indicating a possible typographical error. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012208","obo:HP_0000246","obo:HP_0012735","obo:HP_0001696","obo:HP_0012258","obo:HP_0002205","obo:HP_0031417","obo:HP_0002110","obo:HP_0002090","obo:HP_0012265","obo:HP_0004469"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b6d981b6-2802-4b2a-8fdd-299fa2dfe475_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/098c6637-9b9e-42ce-b2bd-63d66f3c9521_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a3dce89-f762-4ec3-8026-8f36eba06b72","type":"EvidenceLine","dc:description":"This nonsense variant in exon 7 is predicted to either trigger nonsense mediated decay or disrupt ~71% of the protein product. Down-scoring was performed to reflect the homozygous state, and the reported parental consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a3dce89-f762-4ec3-8026-8f36eba06b72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/8cc503d3-7b7a-4db4-8cc8-1d0b7987eaba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1006C>T (p.Gln336Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA294887537"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/098c6637-9b9e-42ce-b2bd-63d66f3c9521","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD133-II:3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8cc503d3-7b7a-4db4-8cc8-1d0b7987eaba"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012258","obo:HP_0002205","obo:HP_0000246","obo:HP_0000388","obo:HP_0031417","obo:HP_0012735","obo:HP_0012265","obo:HP_0012387"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4a3dce89-f762-4ec3-8026-8f36eba06b72_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1a1071c8-e164-427d-88ce-1b068b33788b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdc10137-3157-4728-96bf-8b68001db8b6","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdc10137-3157-4728-96bf-8b68001db8b6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1a1071c8-e164-427d-88ce-1b068b33788b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC455-II:1,","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":41,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002110","obo:HP_0000246","obo:HP_0002090","obo:HP_0012258","obo:HP_0031417","obo:HP_0001696","obo:HP_0002205","obo:HP_0012387","obo:HP_0000388","obo:HP_0012265","obo:HP_0012735","obo:HP_0008222"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cdc10137-3157-4728-96bf-8b68001db8b6_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/231fad80-ad50-4374-9359-dd3ed5204dcc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05a1dc36-648e-4a7e-b655-66d705dde0a1","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.940-2A>G is a splice site variant in intron 6 that is predicted to trigger a frameshift disrupting ~73% of the protein product. It has been only conservatively up-scored due to the absence of functional data confirming this effect.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05a1dc36-648e-4a7e-b655-66d705dde0a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/c82a9f75-9b1c-443b-a244-edf3b8fe63ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.940-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8813631"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c3b8e9ec-067b-4f0d-b7d0-fd5c607763f5","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.344del (p.Pro115Argfs52) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift disrupting ~90% of the protein product.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3b8e9ec-067b-4f0d-b7d0-fd5c607763f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/bea393f6-53af-4d3f-b551-d2835491d549","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.344del (p.Pro115ArgfsTer52)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8813419"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/231fad80-ad50-4374-9359-dd3ed5204dcc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC299-II:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":36,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c82a9f75-9b1c-443b-a244-edf3b8fe63ed"},{"id":"https://genegraph.clinicalgenome.org/r/bea393f6-53af-4d3f-b551-d2835491d549"}],"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012258","obo:HP_0001696","obo:HP_0000246","obo:HP_0031417","obo:HP_0012265","obo:HP_0000388","obo:HP_0012735","obo:HP_0002643","obo:HP_0002090","obo:HP_0002205","obo:HP_0002110","obo:HP_0012387"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c3b8e9ec-067b-4f0d-b7d0-fd5c607763f5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/05a1dc36-648e-4a7e-b655-66d705dde0a1_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/64d07cea-8a50-4e3b-bebc-a6beae4558e0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86280e99-2c02-4f38-9e64-eacd9a9713ce","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86280e99-2c02-4f38-9e64-eacd9a9713ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/64d07cea-8a50-4e3b-bebc-a6beae4558e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC176-III:2","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0003363","obo:HP_0001629","obo:HP_0002205","obo:HP_0025576","obo:HP_0012258","obo:HP_0000388","obo:HP_0012265","obo:HP_0012387","obo:HP_0002643","obo:HP_0012735"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/86280e99-2c02-4f38-9e64-eacd9a9713ce_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/937fd063-57b3-4827-8dbc-313fb35a0c37_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61df1d2a-ae4b-4528-b2ee-9481c183862f","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61df1d2a-ae4b-4528-b2ee-9481c183862f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/937fd063-57b3-4827-8dbc-313fb35a0c37","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC553-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":47,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0008222","obo:HP_0000246","obo:HP_0012265","obo:HP_0002110","obo:HP_0012735","obo:HP_0012387","obo:HP_0002090","obo:HP_0001696","obo:HP_0002205","obo:HP_0012258","obo:HP_0031417","obo:HP_0000388"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/61df1d2a-ae4b-4528-b2ee-9481c183862f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1e74eb5c-6713-4f34-af25-e012279ef34a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2d6154f-bddc-4287-9368-cd2acc1d0955","type":"EvidenceLine","dc:description":"This short deletion variant in exon 10 introduces a frameshift that is predicted to either trigger nonsense mediated decay or disrupt ~55% of the protein product. Down-scoring was performed to reflect the homozygous state, despite the reported parental non-consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2d6154f-bddc-4287-9368-cd2acc1d0955_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/60c2a426-5f00-449c-a021-07240eefe956","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1528_1558del (p.Asp510SerfsTer23)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8813872"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1e74eb5c-6713-4f34-af25-e012279ef34a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_OP-712II1","allele":{"id":"https://genegraph.clinicalgenome.org/r/60c2a426-5f00-449c-a021-07240eefe956"},"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Staining for ciliary GAS11 was negative. Abnormality of cilium morphology was specifically delocalization of radial spoke / central pair.","phenotypes":["obo:HP_0012258","obo:HP_0005938","obo:HP_0001696","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b2d6154f-bddc-4287-9368-cd2acc1d0955_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9122dbce-2ef9-430c-b5f1-865b13f2c94a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5611ce6-e836-49bb-a7a0-77d466bb46cc","type":"EvidenceLine","dc:description":"This single base deletion variant in exon 19 is predicted to trigger a frameshift that disrupts ~9% of the protein product. The variant was not further up-scored due to the homozygous state, despite the lack of evidence for parental consanguinity.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5611ce6-e836-49bb-a7a0-77d466bb46cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f871715-6654-40d2-8857-70786f44263f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.3129del (p.Phe1044fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/573257"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9122dbce-2ef9-430c-b5f1-865b13f2c94a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_OP-76II1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f871715-6654-40d2-8857-70786f44263f"},"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ciliary dyskinesia was specifically characterized by stiff cilia with reduced amplitude. Staining for ciliary DNALI1, GAS11, and CCDC39 was negative.","phenotypes":["obo:HP_0012265","obo:HP_0001696","obo:HP_0012258"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f5611ce6-e836-49bb-a7a0-77d466bb46cc_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e95aca77-c636-4b71-8486-be177971075f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a97e193-6280-4c4b-8c8f-0bd72bd6614b","type":"EvidenceLine","dc:description":"This single base deletion variant in exon 3 is predicted to trigger a frameshift that disrupts ~93% of the protein product. Down-scoring was performed to reflect the homozygous state, despite the reported parental non-consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a97e193-6280-4c4b-8c8f-0bd72bd6614b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e95aca77-c636-4b71-8486-be177971075f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_F-727II1","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ciliary dyskinesia was specifically characterized by stiff cilia with reduced amplitude. Staining for ciliary GAS11 was negative.","phenotypes":["obo:HP_0001696","obo:HP_0012258","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1a97e193-6280-4c4b-8c8f-0bd72bd6614b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0c624a1e-1e7a-49d2-a7b6-f195ef6ff958_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/651e0486-8f48-4071-b866-bba2caa81e76","type":"EvidenceLine","dc:description":"This nonsense variant in exon 19 is predicted to trigger either nonsense mediated decay or truncation disrupting ~7% of the protein product. This variant was moderately up-scored despite the conservative nature of the predicted truncation, the absence of evidence regarding nonsense mediated decay, and its presence in a homozygous state.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/651e0486-8f48-4071-b866-bba2caa81e76_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/a85fb417-ebeb-4e14-8da4-fafd13a78638","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.3175C>T (p.Arg1059Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA401356832"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0c624a1e-1e7a-49d2-a7b6-f195ef6ff958","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_OP-559","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a85fb417-ebeb-4e14-8da4-fafd13a78638"},"detectionMethod":" PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. The otitis media required repeated grommet insertion. The cough was present since birth. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0031417","obo:HP_0012258","obo:HP_0100582","obo:HP_0002205","obo:HP_0012387","obo:HP_0000246","obo:HP_0008222","obo:HP_0000388","obo:HP_0012265","obo:HP_0012735"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/651e0486-8f48-4071-b866-bba2caa81e76_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/643494d3-6e6d-428e-b9ff-67acf1c720e1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/141364c1-02e9-4670-87cd-ce93523db174","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/141364c1-02e9-4670-87cd-ce93523db174_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/643494d3-6e6d-428e-b9ff-67acf1c720e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC336-II:1,","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002205","obo:HP_0002090","obo:HP_0031417","obo:HP_0000246","obo:HP_0012258","obo:HP_0012387","obo:HP_0012265","obo:HP_0000388","obo:HP_0012735"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/141364c1-02e9-4670-87cd-ce93523db174_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/736d68c3-45c6-4372-8b50-902dd52141ff_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bf22587-8415-46ac-8a77-c9060c0bb677","type":"EvidenceLine","dc:description":"This nonsense variant in exon 12 introduces a premature stop codon that is predicted to either trigger nonsense mediated decay or disrupt ~43% of the protein product. Down-scoring was performed to reflect the homozygous state, despite the lack of evidence for parental non-consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bf22587-8415-46ac-8a77-c9060c0bb677_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/11516ee4-e24f-4dae-abf8-ab9c6434ba76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1951C>T (p.Gln651Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259987"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/736d68c3-45c6-4372-8b50-902dd52141ff","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_OP-57II","allele":{"id":"https://genegraph.clinicalgenome.org/r/11516ee4-e24f-4dae-abf8-ab9c6434ba76"},"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Staining for ciliary GAS11 was negative. Abnormality of cilium morphology was specifically delocalization of radial spoke / central pair.","phenotypes":["obo:HP_0005938","obo:HP_0012265","obo:HP_0001696","obo:HP_0012258"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2bf22587-8415-46ac-8a77-c9060c0bb677_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1bc60214-de8e-482f-9199-5b913b3eb124_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72f202d5-2bd4-47dd-8a07-f54d0eeebc1c","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72f202d5-2bd4-47dd-8a07-f54d0eeebc1c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1bc60214-de8e-482f-9199-5b913b3eb124","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC507-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0031417","obo:HP_0012265","obo:HP_0012735","obo:HP_0012258","obo:HP_0000388","obo:HP_0000246","obo:HP_0002643","obo:HP_0012387","obo:HP_0002205"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/72f202d5-2bd4-47dd-8a07-f54d0eeebc1c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/5ce06163-aa39-4c48-a0dd-073c079acbe8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca8e7923-36e7-4c28-85c9-f97655841075","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.961C>T (p.Arg321Ter) is a nonsense variant in exon 7 that is predicted to trigger either nonsense mediated decay or a truncation disrupting ~72% of the protein product. This variant was also found to occur in an affected individual from an apparently unrelated family (also from PMID: 23255504).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca8e7923-36e7-4c28-85c9-f97655841075_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/97856c42-cc23-4d00-9e0a-61cca70969f6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4ee3b653-067b-4d08-95d1-0b2ae81e05d0","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.3129del (p.Phe1044fs) is a single base deletion variant in exon 19 that is predicted to trigger a frameshift that disrupts ~9% of the protein product. It was only conservatively up-scored due to its proximity to the C-terminus and the absence of functional data confirming impact on the protein product.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ee3b653-067b-4d08-95d1-0b2ae81e05d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f871715-6654-40d2-8857-70786f44263f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5ce06163-aa39-4c48-a0dd-073c079acbe8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC175-IV:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/1f871715-6654-40d2-8857-70786f44263f"},{"id":"https://genegraph.clinicalgenome.org/r/97856c42-cc23-4d00-9e0a-61cca70969f6"}],"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002090","obo:HP_0012735","obo:HP_0031417","obo:HP_0012265","obo:HP_0000388","obo:HP_0002643","obo:HP_0012258","obo:HP_0000246","obo:HP_0002205","obo:HP_0012387"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ca8e7923-36e7-4c28-85c9-f97655841075_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/4ee3b653-067b-4d08-95d1-0b2ae81e05d0_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/e1bfca90-0156-464a-8938-c4279427511b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec173a0e-b2a0-4241-bf9a-5724f7f3bcca","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec173a0e-b2a0-4241-bf9a-5724f7f3bcca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e1bfca90-0156-464a-8938-c4279427511b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_OP-120","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ciliary dyskinesia was specifically characterized by stiff cilia with reduced amplitude. Staining for ciliary DNALI1, GAS11, and CCDC39 was negative.","phenotypes":["obo:HP_0012265","obo:HP_0012258"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec173a0e-b2a0-4241-bf9a-5724f7f3bcca_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/029ab85e-ef87-44f3-81de-921c0ecf01b1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8958875a-c050-45d2-9752-0b267588dada","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8958875a-c050-45d2-9752-0b267588dada_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/029ab85e-ef87-44f3-81de-921c0ecf01b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC609-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0031417","obo:HP_0000388","obo:HP_0012735","obo:HP_0002643","obo:HP_0000246","obo:HP_0002205","obo:HP_0012265","obo:HP_0002090","obo:HP_0012387","obo:HP_0012258"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8958875a-c050-45d2-9752-0b267588dada_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/a8cc857e-0a85-4f96-b04a-e645c6cf7df3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b0c673e-a217-4113-8836-fb6d8a38226e","type":"EvidenceLine","dc:description":"This single base deletion variant in exon 9 is predicted to trigger a frameshift that disrupts ~59% of the protein product. Down-scoring was performed to reflect the homozygous state and the reported parental consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b0c673e-a217-4113-8836-fb6d8a38226e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/96602a3f-e288-43c9-b05e-7694c798dffe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1416del (p.Ile473fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/581475"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/a8cc857e-0a85-4f96-b04a-e645c6cf7df3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD129-II:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/96602a3f-e288-43c9-b05e-7694c798dffe"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012735","obo:HP_0012265","obo:HP_0002090","obo:HP_0012387","obo:HP_0002110","obo:HP_0000388","obo:HP_0001696","obo:HP_0000246","obo:HP_0002643","obo:HP_0002205","obo:HP_0012258","obo:HP_0031417"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7b0c673e-a217-4113-8836-fb6d8a38226e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4ee00b5d-12e3-491f-8538-2dfd3d4d7571_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6f6a6dc-b502-4cff-a4c3-496af62e401c","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6f6a6dc-b502-4cff-a4c3-496af62e401c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4ee00b5d-12e3-491f-8538-2dfd3d4d7571","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD216-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"Whole exome sequencing, likely followed by Sanger sequencing of PCR-amplified exons and adjacent intronic regions from CCDC39 and CCDC40","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012735","obo:HP_0002643","obo:HP_0002205","obo:HP_0000246","obo:HP_0012258","obo:HP_0012712","obo:HP_0012387","obo:HP_0001696","obo:HP_0031417","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c6f6a6dc-b502-4cff-a4c3-496af62e401c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/eaab6605-ece9-4280-a710-f2e031ab2e46_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb4bedd6-22e7-41cb-bdd5-17061933cf29","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb4bedd6-22e7-41cb-bdd5-17061933cf29_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/eaab6605-ece9-4280-a710-f2e031ab2e46","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC120-IV:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002643","obo:HP_0012265","obo:HP_0002090","obo:HP_0002205","obo:HP_0012735","obo:HP_0000246","obo:HP_0012387","obo:HP_0002110","obo:HP_0000388","obo:HP_0012258","obo:HP_0031417"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cb4bedd6-22e7-41cb-bdd5-17061933cf29_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/51a18f9b-9e1c-4d35-9eb5-cca8f814f9d4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24397e71-2cef-430f-a596-f9662167c30d","type":"EvidenceLine","dc:description":"This nonsense variant in exon 8 introduces a premature stop codon that is predicted to either trigger nonsense mediated decay or truncate ~62% of the protein product. Down-scoring was performed to reflect the homozygous state, despite the absence of evidence for parental consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24397e71-2cef-430f-a596-f9662167c30d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/44154f5b-3b81-41f2-90c7-8748d123857a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1315C>T (p.Gln439Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259985"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/51a18f9b-9e1c-4d35-9eb5-cca8f814f9d4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_OP-240II2","allele":{"id":"https://genegraph.clinicalgenome.org/r/44154f5b-3b81-41f2-90c7-8748d123857a"},"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ciliary dyskinesia was specifically characterized by stiff cilia with reduced amplitude. Staining for ciliary GAS11 was negative.","phenotypes":["obo:HP_0001696","obo:HP_0012258","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/24397e71-2cef-430f-a596-f9662167c30d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/12bb907d-485d-4584-93bc-01d83cc88cfa_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7eda1520-c13f-46ae-b8bd-c487b8393495","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7eda1520-c13f-46ae-b8bd-c487b8393495_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/12bb907d-485d-4584-93bc-01d83cc88cfa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD199-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0031417","obo:HP_0012387","obo:HP_0012735","obo:HP_0012265","obo:HP_0002205","obo:HP_0000246","obo:HP_0012258","obo:HP_0012712"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7eda1520-c13f-46ae-b8bd-c487b8393495_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/649729ab-ad46-4a23-9f4f-33b5128c20cd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b207e295-4e57-421b-aa6a-70cc6dc2260b","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.1345C>T (p.Arg449Ter) is a nonsense variant in exon 9 that is predicted to trigger a frameshift disrupting ~61% of the protein product. Despite its recurrence in an apparently unrelated proband, it has been scored at reduced strength for this proband due to having been previously scored at full strength for the first proband (PMID: 21131974).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b207e295-4e57-421b-aa6a-70cc6dc2260b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea61e3aa-d77d-4aea-8c1a-9cdd0ae3fb1c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1345C>T (p.Arg449Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259989"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/928bea00-b8b7-4254-826f-eb563f921478","type":"EvidenceLine","dc:description":"This single base substitution in an essential splice site in intron 16 is predicted to trigger a frameshift that disrupts ~21% of the protein product. While up-scoring was performed to reflect its recurrence in two other probands from this paper (PMID: 23255504), it was only scored at full strength in the first proband and at half-strength in subsequent ones, including this proband.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/928bea00-b8b7-4254-826f-eb563f921478_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a1bd339-17bd-46c1-a3a8-cad7da84a6f5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/649729ab-ad46-4a23-9f4f-33b5128c20cd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC660-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/ea61e3aa-d77d-4aea-8c1a-9cdd0ae3fb1c"},{"id":"https://genegraph.clinicalgenome.org/r/3a1bd339-17bd-46c1-a3a8-cad7da84a6f5"}],"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0000246","obo:HP_0012735","obo:HP_0012387","obo:HP_0002643","obo:HP_0012265","obo:HP_0031417","obo:HP_0002090","obo:HP_0001696","obo:HP_0012258","obo:HP_0000388","obo:HP_0002205"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b207e295-4e57-421b-aa6a-70cc6dc2260b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/928bea00-b8b7-4254-826f-eb563f921478_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.25},{"id":"https://genegraph.clinicalgenome.org/r/16aacd5d-92e7-4902-ac1b-1d0eef2684b2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/565993ef-7f0f-417e-96ff-323085cc8747","type":"EvidenceLine","dc:description":"This paternally inherited nonsense variant in exon 9 introduces a premature stop codon that is predicted to either trigger nonsense mediated decay or disrupt ~61% of the protein product. The maternally inherited deletion in trans disrupts at least the 5'UTR and exon 1 and is therefore expected to impact the protein product as well.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/565993ef-7f0f-417e-96ff-323085cc8747_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea61e3aa-d77d-4aea-8c1a-9cdd0ae3fb1c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/16aacd5d-92e7-4902-ac1b-1d0eef2684b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_OP-43II1","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea61e3aa-d77d-4aea-8c1a-9cdd0ae3fb1c"},"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing. After a monoallelic (paternal) CCDC40 variant was detected, the proband and his two affected family members were subjected to SNP-based segregation analysis of genotype in order to test for large deletions on the second allele.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Staining for ciliary GAS11 was negative. Abnormality of cilium morphology was specifically delocalization of radial spoke / central pair.","phenotypes":["obo:HP_0001696","obo:HP_0005938","obo:HP_0012265","obo:HP_0012258"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/565993ef-7f0f-417e-96ff-323085cc8747_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5c249d98-a069-4e7d-91b4-672b1ab18919_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74961dfd-8bbe-42a4-8b2d-0696993760a0","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74961dfd-8bbe-42a4-8b2d-0696993760a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/285d58cd-848d-4457-97cd-5fa3abc3d639","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.1810C>T (p.Gln604Ter) is a nonsense variant in exon 12 that is predicted to trigger either nonsense mediated decay or truncation of ~47% of the protein product.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/285d58cd-848d-4457-97cd-5fa3abc3d639_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","allele":{"id":"https://genegraph.clinicalgenome.org/r/33b97b36-9ecd-4640-9aac-95ec18d98681","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1810C>T (p.Gln604Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA401338475"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5c249d98-a069-4e7d-91b4-672b1ab18919","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21131974","rdfs:label":"Becker-Heck_2011_OP-82II1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},{"id":"https://genegraph.clinicalgenome.org/r/33b97b36-9ecd-4640-9aac-95ec18d98681"}],"detectionMethod":"PCR amplification of CCDC40 exons and adjacent intronic regions, followed by Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ciliary dyskinesia was specifically characterized by stiff cilia with reduced amplitude. Staining for ciliary GAS11 was negative. Abnormality of cilium morphology was specifically delocalization of radial spoke / central pair.","phenotypes":["obo:HP_0001696","obo:HP_0005938","obo:HP_0012258","obo:HP_0012265"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Other","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/74961dfd-8bbe-42a4-8b2d-0696993760a0_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/285d58cd-848d-4457-97cd-5fa3abc3d639_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/59a0fa4b-99bc-4686-a197-3c892908d1cb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a1c20a6-4684-48cd-a4b7-1d7659626d5a","type":"EvidenceLine","dc:description":"This single base deletion variant in exon 10 is predicted to trigger a frameshift that disrupts ~57% of the protein product. Down-scoring was performed due to the homozygous state of the variant and the reported parental consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a1c20a6-4684-48cd-a4b7-1d7659626d5a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/327e6c7e-ee16-4ba7-b359-a1f528b625bc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.1464del (p.Ser489AlafsTer18)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA627693582"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/59a0fa4b-99bc-4686-a197-3c892908d1cb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_OP-561","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/327e6c7e-ee16-4ba7-b359-a1f528b625bc"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Otitis media was associated with hearing loss. Recurrent respiratory tract infections led to right middle lobe atelectasis. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012735","obo:HP_0012387","obo:HP_0012265","obo:HP_0000246","obo:HP_0100750","obo:HP_0002090","obo:HP_0012258","obo:HP_0031417","obo:HP_0000388","obo:HP_0002205","obo:HP_0002110"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7a1c20a6-4684-48cd-a4b7-1d7659626d5a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6c35c33e-44de-4b9d-8323-1ef6f61cac90_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db48182e-899a-4207-b2d8-1b049a3e8f77","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db48182e-899a-4207-b2d8-1b049a3e8f77_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6c35c33e-44de-4b9d-8323-1ef6f61cac90","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD17-II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0000388","obo:HP_0002110","obo:HP_0002783","obo:HP_0002205","obo:HP_0000246","obo:HP_0001696","obo:HP_0031417","obo:HP_0002643","obo:HP_0002107","obo:HP_0012265","obo:HP_0012258"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/db48182e-899a-4207-b2d8-1b049a3e8f77_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d8332c2e-1164-4202-b6fe-bce274f3a5fe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71fb35c4-83c4-404a-9352-50bdf646a8d8","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71fb35c4-83c4-404a-9352-50bdf646a8d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d8332c2e-1164-4202-b6fe-bce274f3a5fe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_OP-560","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Otitis media required repeated insertion of grommets. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012387","obo:HP_0012735","obo:HP_0000388","obo:HP_0100582","obo:HP_0002110","obo:HP_0012265","obo:HP_0031417","obo:HP_0002205","obo:HP_0012208","obo:HP_0012258","obo:HP_0000246"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/71fb35c4-83c4-404a-9352-50bdf646a8d8_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c22d34c1-ee98-484a-a041-150945643fbd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/593d733c-900f-4627-b3ae-be9eb9dfb84d","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/593d733c-900f-4627-b3ae-be9eb9dfb84d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c22d34c1-ee98-484a-a041-150945643fbd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_UNC122-III:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0002205","obo:HP_0012265","obo:HP_0031417","obo:HP_0012387","obo:HP_0002090","obo:HP_0012735","obo:HP_0012258","obo:HP_0000388","obo:HP_0002643","obo:HP_0000246","obo:HP_0002110"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/593d733c-900f-4627-b3ae-be9eb9dfb84d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/f900a626-1040-43ce-aab6-743fd18f6475_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0fe8f917-c887-4149-82cf-24cd661991d2","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0fe8f917-c887-4149-82cf-24cd661991d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/870c6c6d-ce36-4d5a-86e7-a701a2da21a3","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.687del (p.Val231CysfsTer) is a frameshift variant predicted to disrupt ~80% of the protein product.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/870c6c6d-ce36-4d5a-86e7-a701a2da21a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1264fe6-7d77-427c-8023-9459827a1269","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017950.4(CCDC40):c.687del (p.Val231CysfsTer57)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2497030231"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f900a626-1040-43ce-aab6-743fd18f6475","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_KUL-001-II:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},{"id":"https://genegraph.clinicalgenome.org/r/b1264fe6-7d77-427c-8023-9459827a1269"}],"detectionMethod":"Whole exome sequencing likely followed by PCR amplification of exons and adjacent intronic regions, followed by Sanger sequencing of CCDC39 and CCDC40","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Otitis media required repeated insertion of grommets. Perinatal respiratory symptoms included secretions since birth. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0012258","obo:HP_0002205","obo:HP_0000246","obo:HP_0031417","obo:HP_0012387","obo:HP_0002110","obo:HP_0000388","obo:HP_0100582","obo:HP_0012735","obo:HP_0012265","obo:HP_0012208"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/870c6c6d-ce36-4d5a-86e7-a701a2da21a3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0fe8f917-c887-4149-82cf-24cd661991d2_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/58f9f365-c2c3-4591-afbe-aec6af1e92b6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5445af63-d29a-40ca-bff4-64df0c2047a7","type":"EvidenceLine","dc:description":"NM_017950.4(CCDC40):c.248del (p.Ala83fs) is a single base deletion variant in exon 3 that is predicted to trigger a frameshift that disrupts ~93% of the protein product. Despite its recurrence in multiple probands, down-scoring (to half original score) was performed since it was already scored at full strength for the first proband (PMID: 21131974).","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5445af63-d29a-40ca-bff4-64df0c2047a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/58f9f365-c2c3-4591-afbe-aec6af1e92b6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23255504","rdfs:label":"Antony_2013_PCD147-II:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/096cf27a-448d-4f6b-b4d7-a1b0f1fe41fa"},"detectionMethod":"Whole exome sequencing, likely followed by Sanger sequencing of PCR-amplified exons and adjacent intronic regions from CCDC39 and CCDC40","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Prior to genotyping, the proband was previously diagnosed with classic PCD and axonemal ultrastructural defects previously known to be characteristic of CCDC39 and CCDC40 variants. Respiratory bronchial epithelial cell TEM showed disorganization of peripheral microtubule doublets, absence or shifting of central pairs, and reduction or loss of inner dynein arms.","phenotypes":["obo:HP_0031417","obo:HP_0002110","obo:HP_0002205","obo:HP_0000246","obo:HP_0002643","obo:HP_0012735","obo:HP_0012387","obo:HP_0012265","obo:HP_0012258"],"previousTesting":false,"previousTestingDescription":"Previous testing appears to have been clinical characterization of phenotypes rather than genetic.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5445af63-d29a-40ca-bff4-64df0c2047a7_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":3753,"specifiedBy":"GeneValidityCriteria8","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/GxSi_pL4g_Q","type":"GeneValidityProposition","disease":"obo:MONDO_0013435","gene":"hgnc:26090","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e9c192c6-9f74-4beb-85ba-a42199e9794a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}